Ariad Pharmaceuticals Inc fka ARIA

[lax20m]

Oooh DNDN looks awful, Im glad I stopped selling puts in that stock some time ago. If its down as much as it is in the after market it might be a good buy.

I think what happened to DNDN should be a wake up call to ARIAD management. I know we all hope that we don't partner Pona or 113 so that we can keep all the profits. But often that can be a real downfall for a biotech. They spend 5-20 years developing drugs and they want to keep all the profits but when it gets time to market their approved drug they don't know what they are doing. Drugs that are seemingly great don't take off because the company has no experience with that side of the business.... That might not be what is going on at Dendreon....... but its the first thing that came to my mind.

Another investment of mine comes to mind with respect to a failed marketing effort..... Abraxane. I still don't understand why that cancer drug didn't capture 100% of the metastatic breast cancer market. Eventually they figured out they didn't know what they were doing with the marketing and partnered with Astra Zeneca only to have that fail and buy the rights back from astra zeneca. Anywhoo you are right tomorrow should be interesting...... but lately, interesting is par for the course.